O. Salomon et al., ANALYSIS OF GENETIC POLYMORPHISMS RELATED TO THROMBOSIS AND OTHER RISK-FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION, Blood coagulation & fibrinolysis, 9(7), 1998, pp. 617-622
The purpose of this study was to investigate the role of genetic polym
orphisms associated with venous and arterial thrombosis in patients wi
th retinal vein occlusion (RVO). One-hundred and two consecutive patie
nts with RVO were examined for factor V G1691A and factor II G20210A,
methylenetetrahydrofolate reductase (MTHFR) C677T and apolipoprotein E
-4 by amplification of specific DNA fragments and restriction analysis
. The risks exerted by these polymorphisms and by the conventional ris
k factors of RVO were evaluated by comparing their frequencies among p
atients and controls and by estimating the respective odds ratios. We
found that the prevalences of the factor V G1691A, factor ZI G20210A,
and apolipoprotein E-4 polymorphisms were similar in the study and con
trol groups. Logistic regression analysis involving the parameters far
which significant differences were detected disclosed an odds ratio o
f 1.9 for MTHFR C677T homozygosity (95% confidence interval 0.95-3.81)
, an odds ratio of 2.12 for hypertension (95% confidence interval 1.16
-3.73) and an odds ratio of 3.25 for a family history of stroke (95% c
onfidence interval 1.07-9.51). Our data suggests that homozygosity for
the MTHFR C677T polymorphism is a risk factor of RVO in addition to a
rterial hypertension and a family history of stroke. (C) 1998 Lippinco
tt Williams & Wilkins.